We are live on ! Find out more
INZY

Inozyme Pharma

Delisted

INZY was delisted on the 30th of June, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
NHAS
1
Novo Holdings A/S
Denmark
$53M
NMC
2
NEA Management Company
Maryland
$50.5M
SI
3
Sofinnova Investments
California
$41.9M
RCM
4
RA Capital Management
Massachusetts
$41.4M
PBPIA
5
Pivotal bioVenture Partners Investment Advisor
California
$32.8M +$37.9M +1,591,154 New
DM
6
Deerfield Management
New York
$23.7M
CA
7
CHI Advisors
New York
$20.5M -$327K -13,721 -1%
Adage Capital Partners
8
Adage Capital Partners
Massachusetts
$18.5M +$2.3M +96,672 +12%
RSCM
9
Rock Springs Capital Management
Maryland
$17.1M -$1.18M -49,408 -6%
BlackRock
10
BlackRock
New York
$13M +$3.09M +129,817 +26%
Fidelity Investments
11
Fidelity Investments
Massachusetts
$12.6M
Wellington Management Group
12
Wellington Management Group
Massachusetts
$9.05M +$3.19M +134,012 +44%
O
13
OrbiMed
New York
$8.26M
Vanguard Group
14
Vanguard Group
Pennsylvania
$6.38M +$288K +12,077 +4%
Citadel Advisors
15
Citadel Advisors
Florida
$5.21M +$273K +11,464 +5%
SCM
16
Suvretta Capital Management
New York
$4.42M +$5.11M +214,311 New
BCM
17
Burrage Capital Management
Massachusetts
$3.52M +$4.07M +170,796 New
State Street
18
State Street
Massachusetts
$2.43M +$1.12M +46,994 +67%
YU
19
Yale University
Connecticut
$2.34M
BBA
20
Baker Bros. Advisors
New York
$2.21M -$274K -11,501 -10%
Geode Capital Management
21
Geode Capital Management
Massachusetts
$2.2M +$194K +8,162 +8%
Northern Trust
22
Northern Trust
Illinois
$1.92M +$1K +42 +0%
Charles Schwab
23
Charles Schwab
California
$1.01M +$16.9K +711 +1%
Bank of New York Mellon
24
Bank of New York Mellon
New York
$440K +$46.8K +1,964 +10%
Nuveen
25
Nuveen
North Carolina
$439K +$101K +4,222 +25%